Skip to main content
. Author manuscript; available in PMC: 2015 Sep 27.
Published in final edited form as: J Evid Based Complementary Altern Med. 2014 Mar 27;19(3):161–175. doi: 10.1177/2156587214525403

Table 1.

Natural Standard evidence-based validated grading rationale.

Level of evidence grade Criteria
A (Strong scientific evidence) Statistically significant evidence of benefit from >2 properly randomized trials (RCTs), OR evidence from one properly conducted RCT AND one properly conducted meta-analysis, OR evidence from multiple RCTs with a clear majority of the properly conducted trials showing statistically significant evidence of benefit AND with supporting evidence in basic science, animal studies, or theory.
B (Good scientific evidence) Statistically significant evidence of benefit from 1–2 properly randomized trials, OR evidence of benefit from >1 properly conducted meta-analysis OR evidence of benefit from >1 cohort/case-control/non-randomized trials AND with supporting evidence in basic science, animal studies, or theory.
C (Unclear or conflicting scientific evidence) Evidence of benefit from >1 small RCT(s) without adequate size, power, statistical significance, or quality of design by objective criteria, OR conflicting evidence from multiple RCTs without a clear majority of the properly conducted trials showing evidence of benefit or ineffectiveness, OR evidence of benefit from >1 cohort/case-control/non-randomized trials AND without supporting evidence in basic science, animal studies, or theory, OR evidence of efficacy only from basic science, animal studies, or theory.
D (Fair negative scientific evidence) Statistically significant negative evidence (i.e., lack of evidence of benefit) from cohort/case-control/non-randomized trials, AND evidence in basic science, animal studies, or theory suggesting a lack of benefit.
F (Strong negative scientific evidence) Statistically significant negative evidence (i.e., lack of evidence of benefit) from >1 properly randomized adequately powered trial(s) of high-quality design by objective criteria.
Lack of evidence Unable to evaluate efficacy due to lack of adequate available human data.